FDA Registration for Selling Sunscreen in the U.S.
Why sunscreen is an OTC drug, what it takes to sell it, the GRASE active-ingredient status, and the Drug Facts labeling that trips brands up.
Key Takeaways
- Sunscreen is an OTC drug, not a cosmetic — SPF is a drug claim.
- Cosmetic/MoCRA registration doesn't cover it — you need the OTC drug package.
- Registration + labeler code + NDC + Drug Facts + cGMP + OMUFA — the requirements.
- Only zinc oxide & titanium dioxide are clearly GRASE — the mineral filters.
- PABA & trolamine salicylate removed (2026) — others need more data but remain sellable.
- No "waterproof" or "sunblock" — only "Water Resistant (40/80 minutes)."
In the U.S., Sunscreen Is a Drug
In much of the world sunscreen is a cosmetic. In the United States it isn't: because a sunscreen is intended to help prevent sunburn and reduce the risks of UV exposure, that's a drug claim, and FDA regulates sunscreen as an over-the-counter (OTC) drug. Selling it in a beauty aisle, packaging it with skincare, or marketing it through a cosmetics brand doesn't change that.
What It Takes to Sell Sunscreen
- Drug establishment registration — the manufacturing facility registers under 21 CFR Part 207 (foreign facilities also need a U.S. Agent)
- Labeler code & NDC listing — each product listed with an NDC, submitted in SPL
- Drug Facts labeling — active ingredients, uses, warnings, directions, SPF, and any Broad Spectrum / Water Resistant statements
- Monograph-compliant active ingredients — permitted UV filters at allowed concentrations (see below)
- cGMP manufacturing — under 21 CFR Parts 210 & 211
- OMUFA facility fees — the annual OTC Monograph User Fee for OTC drug (including sunscreen) facilities
Active Ingredients & GRASE Status
Under OTC Monograph M020 (modernized through the CARES Act reform), FDA has sorted the sunscreen UV filters by whether they're GRASE — Generally Recognized as Safe and Effective:
| Active ingredient(s) | Status | What it means |
|---|---|---|
| Zinc oxide, titanium dioxide (mineral) | GRASE | Recognized safe & effective (up to 25%) |
| PABA, trolamine salicylate | Not GRASE | Removed from the monograph (2026 final order) over safety |
| Oxybenzone, avobenzone, octocrylene, homosalate, octinoxate, octisalate, and others | Data needed | Still marketable, but FDA has requested more safety data |
| Bemotrizinol | Newly proposed | First new UV filter proposed in decades (Dec 2025) |
Drug Facts, SPF & Claims
- Drug Facts panel — active ingredients & purpose, uses, warnings, directions, inactive ingredients
- SPF value — supported by testing
- Broad Spectrum — only if the product passes FDA's broad-spectrum test (proportional UVA to UVB)
- Water Resistant (40 or 80 minutes) — with the specific time, supported by testing
- Skin Cancer/Skin Aging Alert — required if the product is not Broad Spectrum, or is Broad Spectrum with SPF 2–14
- No "waterproof," "sweatproof," "sunblock," or "all-day" — these overstate protection and aren't allowed
Who Needs What
| You are… | Typically need | Common mistake |
|---|---|---|
| U.S. sunscreen brand | Labeler code, NDC listing, Drug Facts & claims review | Assuming the contract manufacturer handles every FDA duty |
| Foreign manufacturer | Establishment registration, U.S. Agent, NDC listing, label review | Shipping sunscreen as a cosmetic (no OTC listing/Drug Facts) |
| Private-label seller | Labeler code, NDC, label artwork & formula review | Reusing a supplier's foreign label without U.S. review |
| Amazon seller | Registration evidence, NDC, compliant Drug Facts, claims review | Listing with beauty claims and no OTC drug evidence |
| Importer / distributor | Entry docs, manufacturer registration, listing, label review | Expecting the broker to fix registration/labeling after arrival |
Get Your Sunscreen FDA-Compliant
FDA Registration Assistance handles the OTC drug side of sunscreen: drug establishment registration, labeler code and NDC listing, Drug Facts/SPF/Broad Spectrum/Water Resistant label review, active-ingredient and claims review against the sunscreen monograph, U.S. Agent for foreign manufacturers, and import documentation — so your product is compliant before you manufacture, label, list, import, or sell.
Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a quote. An independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience.
Frequently Asked Questions — Selling Sunscreen in the U.S.
1. Is sunscreen a cosmetic or a drug in the U.S.?
In the United States, sunscreen is regulated as an over-the-counter (OTC) drug — not a cosmetic — because it's intended to help prevent sunburn and reduce the risks of UV exposure, which is a drug claim. This surprises many brands, because in much of the world sunscreen is a cosmetic. Selling it in a beauty aisle, or by a skincare brand, doesn't change it: the sun-protection function creates OTC drug obligations.
2. Does cosmetic (MoCRA) registration cover sunscreen?
No. Because sunscreen is an OTC drug, a cosmetic facility registration or MoCRA filing does not satisfy the OTC drug obligations. Selling sunscreen requires drug establishment registration, a labeler code and NDC drug listing, Drug Facts labeling, cGMP, and (for OTC drug facilities) OMUFA fees. If your product also makes cosmetic claims, both frameworks can apply — but the drug side is mandatory for the sun-protection function.
3. What does it take to sell sunscreen in the U.S.?
The OTC drug package: drug establishment registration (21 CFR Part 207) for the manufacturing facility; a labeler code and NDC drug listing for each product (in SPL); a compliant Drug Facts label with the correct SPF, Broad Spectrum, and water-resistance statements; cGMP manufacturing; OMUFA (OTC Monograph User Fee) facility fees; and, for foreign facilities, a U.S. Agent. Monograph-compliant active ingredients underpin all of it.
4. Which sunscreen active ingredients are FDA GRASE?
Only two are currently recognized as GRASE (Generally Recognized as Safe and Effective): zinc oxide and titanium dioxide — the mineral filters, at concentrations up to 25%. PABA and trolamine salicylate have been determined not GRASE (removed from the sunscreen monograph in a 2026 final order due to safety concerns). The remaining chemical filters — oxybenzone, avobenzone, octocrylene, homosalate, octinoxate, octisalate, and others — are not yet classified as GRASE because FDA has requested more safety data.
5. Can I still sell sunscreen with oxybenzone or avobenzone?
Yes, for now. The chemical filters that FDA says need more data (oxybenzone, avobenzone, octocrylene, homosalate, octinoxate, octisalate, and others) can still be marketed under the sunscreen monograph's deemed final order, which preserves the status quo. It's important to understand this is about data, not a ban: FDA is requesting additional safety information, not prohibiting these ingredients. Their status could change once the data is evaluated, so it's worth tracking.
6. What is the OTC sunscreen monograph (M020)?
OTC Monograph M020 is the framework that sets the conditions under which sunscreens can be marketed without a new-drug application — permitted active ingredients and concentrations, SPF and broad-spectrum requirements, dosage forms, and labeling. Under the CARES Act (2020) OTC monograph reform, sunscreen moved to a "deemed final order" and an administrative-order process, which is how FDA now updates it — including a December 2025 proposal to add bemotrizinol, the first new UV filter proposed in decades.
7. Do sunscreen companies need FDA drug establishment registration?
Facilities that manufacture, process, pack, or relabel OTC sunscreen generally must have FDA drug establishment registration (21 CFR Part 207), and each product must be listed with an NDC. This is separate from — and not covered by — cosmetic or food facility registration. Whether your specific role requires registration depends on what you do (manufacturer, labeler, distributor), which is worth confirming before launch.
8. What is a labeler code and NDC for sunscreen?
A labeler code identifies the firm responsible for marketing the product under its label; it forms the first segment of the National Drug Code (NDC), the unique identifier for each listed OTC drug product. Sunscreens marketed as OTC drugs generally need a labeler code and an NDC drug listing (submitted in SPL). Private-label brands in particular should confirm who holds the labeler code and NDC responsibility.
9. What is OMUFA and does it apply to sunscreen?
OMUFA is the OTC Monograph User Fee program: manufacturers of OTC monograph drugs — which includes sunscreen — pay an annual facility fee to FDA. It's a real, recurring cost of being in the OTC sunscreen business that's easy to overlook when a company assumes sunscreen is just a cosmetic. Budgeting for OMUFA is part of planning a U.S. sunscreen launch.
10. What must a sunscreen Drug Facts label include?
A compliant sunscreen label carries a Drug Facts panel with active ingredients and their purpose, a "Uses" statement, warnings (including the required alerts), directions (application, reapplication, children, water exposure), and inactive ingredients — plus the SPF value and any Broad Spectrum and Water Resistant statements. It's more involved than a cosmetic label, and getting it wrong makes the product misbranded.
11. What does "Broad Spectrum" mean on a sunscreen?
"Broad Spectrum" means the product passed FDA's broad-spectrum test, demonstrating proportional UVA protection relative to its UVB (SPF) protection. Only products that pass may use the claim. It matters for the warnings too: a sunscreen that is not Broad Spectrum (or is Broad Spectrum with SPF 2–14) must carry a Skin Cancer/Skin Aging Alert stating it hasn't been shown to help prevent skin cancer or early skin aging.
12. Can I call my sunscreen "waterproof" or "sunblock"?
No. FDA doesn't allow "waterproof," "sweatproof," or "sunblock" — they overstate protection. What's permitted is a "Water Resistant" claim with a specific time, either 40 minutes or 80 minutes, supported by testing, telling consumers how long the SPF holds during swimming or sweating. Terms like "all-day protection" are also problematic. Claims should be reviewed across the label, packaging, website, and marketplace listing.
13. Does FDA approve sunscreen before it's sold?
Not in the new-drug-application sense. Sunscreens marketed under the OTC monograph aren't "approved" the way an NDA drug is; instead they must comply with the monograph's conditions (active ingredients, SPF/broad-spectrum, labeling) plus registration and listing. So there's no FDA "approval" to cite — claiming "FDA approved" for a monograph sunscreen is itself a compliance problem. It's compliance, not approval.
14. Do foreign sunscreen manufacturers need extra steps?
Yes. A foreign sunscreen manufacturer needs drug establishment registration, a U.S. Agent (21 CFR 207.69), NDC listing, cGMP, and fully U.S.-compliant Drug Facts labeling before export — and the U.S. importer handles the entry. Shipping sunscreen to the U.S. as a "cosmetic," without OTC drug registration, listing, and Drug Facts labeling, is one of the most common (and costly) mistakes foreign brands make.
15. Can I sell sunscreen on Amazon without FDA documentation?
Amazon (and other marketplaces/retailers) frequently request FDA documentation for sunscreen — registration evidence, NDC information, and compliant Drug Facts labels — because it's an OTC drug. Sellers should prepare this before listing or sending inventory to FBA, since being asked mid-launch leaves little time to fix registration, listing, or labeling gaps.
16. Can imported sunscreen be detained by FDA?
Yes. FDA can detain imported sunscreen that appears misbranded (non-compliant Drug Facts/claims), unlisted, made by an unregistered establishment, or that uses active ingredients or claims outside the OTC pathway. Because sunscreen is a drug, the entry is reviewed against drug requirements — so a product that would pass as a cosmetic elsewhere can be held at a U.S. port.
17. What are the most common sunscreen compliance mistakes?
Treating sunscreen as a cosmetic and skipping OTC drug registration/listing/Drug Facts; printing labels before a Drug Facts review; assuming a foreign supplier's formula and label meet U.S. rules; using non-compliant claims ("waterproof," "sunblock," "all-day"); and overlooking OMUFA fees. Nearly all trace back to the same root cause — not recognizing that U.S. sunscreen is a drug.
18. How does FDA Registration Assistance help with sunscreen?
We handle the OTC drug side: drug establishment registration, labeler code and NDC listing, Drug Facts/SPF/Broad Spectrum/Water Resistant label review, active-ingredient and claims review against the sunscreen monograph, U.S. Agent for foreign manufacturers, and import documentation — so your sunscreen is compliant before you manufacture, label, list, import, or sell. We're an independent compliance firm serving 1,000+ companies across 135+ countries with 15+ years of experience. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333.
